 | • レポートコード：QYR2104Z5540 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、全身性乾癬治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子）、用途別市場規模（軽度乾癬、中等度乾癬、重度乾癬）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・全身性乾癬治療薬の市場動向 ・企業の競争状況、市場シェア ・全身性乾癬治療薬の種類別市場規模（生物製剤、小分子） ・全身性乾癬治療薬の用途別市場規模（軽度乾癬、中等度乾癬、重度乾癬） ・全身性乾癬治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・全身性乾癬治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・全身性乾癬治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・全身性乾癬治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・全身性乾癬治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Johnson & Johnson、Celgene、Amgen、Pfizer） ・結論 |
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.
Market Analysis and Insights: Global Systemic Psoriasis Therapeutics Market
The global Systemic Psoriasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Psoriasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Psoriasis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Psoriasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Psoriasis Therapeutics market.
Global Systemic Psoriasis Therapeutics Scope and Market Size
Systemic Psoriasis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biologics
Small Molecules
Segment by Application
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Johnson & Johnson
Celgene
Amgen
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Systemic Psoriasis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mild Psoriasis
1.3.3 Moderate Psoriasis
1.3.4 Severe Psoriasis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Systemic Psoriasis Therapeutics Market Perspective (2016-2027)
2.2 Systemic Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Systemic Psoriasis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Systemic Psoriasis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Systemic Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Systemic Psoriasis Therapeutics Industry Dynamic
2.3.1 Systemic Psoriasis Therapeutics Market Trends
2.3.2 Systemic Psoriasis Therapeutics Market Drivers
2.3.3 Systemic Psoriasis Therapeutics Market Challenges
2.3.4 Systemic Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Systemic Psoriasis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Systemic Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Systemic Psoriasis Therapeutics Revenue
3.4 Global Systemic Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Systemic Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Psoriasis Therapeutics Revenue in 2020
3.5 Systemic Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Systemic Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Systemic Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027)
5 Systemic Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Systemic Psoriasis Therapeutics Market Size (2016-2027)
6.2 North America Systemic Psoriasis Therapeutics Market Size by Type
6.2.1 North America Systemic Psoriasis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Systemic Psoriasis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Systemic Psoriasis Therapeutics Market Size by Type (2016-2027)
6.3 North America Systemic Psoriasis Therapeutics Market Size by Application
6.3.1 North America Systemic Psoriasis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Systemic Psoriasis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Systemic Psoriasis Therapeutics Market Size by Application (2016-2027)
6.4 North America Systemic Psoriasis Therapeutics Market Size by Country
6.4.1 North America Systemic Psoriasis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Systemic Psoriasis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Systemic Psoriasis Therapeutics Market Size (2016-2027)
7.2 Europe Systemic Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Systemic Psoriasis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Systemic Psoriasis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Systemic Psoriasis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Systemic Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Systemic Psoriasis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Systemic Psoriasis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Systemic Psoriasis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Systemic Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Systemic Psoriasis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Systemic Psoriasis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Systemic Psoriasis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Systemic Psoriasis Therapeutics Market Size (2016-2027)
9.2 Latin America Systemic Psoriasis Therapeutics Market Size by Type
9.2.1 Latin America Systemic Psoriasis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Systemic Psoriasis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Systemic Psoriasis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Systemic Psoriasis Therapeutics Market Size by Application
9.3.1 Latin America Systemic Psoriasis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Systemic Psoriasis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Systemic Psoriasis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Systemic Psoriasis Therapeutics Market Size by Country
9.4.1 Latin America Systemic Psoriasis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Systemic Psoriasis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Psoriasis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction
11.1.4 AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Systemic Psoriasis Therapeutics Introduction
11.3.4 Celgene Revenue in Systemic Psoriasis Therapeutics Business (2016-2021)
11.3.5 Celgene Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Systemic Psoriasis Therapeutics Introduction
11.4.4 Amgen Revenue in Systemic Psoriasis Therapeutics Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction
11.5.4 Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecules
Table 4. Global Systemic Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Systemic Psoriasis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Systemic Psoriasis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Systemic Psoriasis Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Systemic Psoriasis Therapeutics Market Share by Regions (2022-2027)
Table 10. Systemic Psoriasis Therapeutics Market Trends
Table 11. Systemic Psoriasis Therapeutics Market Drivers
Table 12. Systemic Psoriasis Therapeutics Market Challenges
Table 13. Systemic Psoriasis Therapeutics Market Restraints
Table 14. Global Systemic Psoriasis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Systemic Psoriasis Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Psoriasis Therapeutics as of 2020)
Table 17. Ranking of Global Top Systemic Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Systemic Psoriasis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Systemic Psoriasis Therapeutics Product Solution and Service
Table 21. Date of Enter into Systemic Psoriasis Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Systemic Psoriasis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Systemic Psoriasis Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Systemic Psoriasis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Systemic Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Systemic Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Systemic Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Systemic Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Systemic Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Systemic Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Systemic Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Systemic Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Systemic Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Systemic Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Systemic Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Systemic Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Systemic Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Systemic Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Systemic Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Systemic Psoriasis Therapeutics Product
Table 64. AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Systemic Psoriasis Therapeutics Product
Table 69. Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Celgene Company Details
Table 72. Celgene Business Overview
Table 73. Celgene Systemic Psoriasis Therapeutics Product
Table 74. Celgene Revenue in Systemic Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Celgene Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Systemic Psoriasis Therapeutics Product
Table 79. Amgen Revenue in Systemic Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Systemic Psoriasis Therapeutics Product
Table 84. Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Psoriasis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Small Molecules Features
Figure 4. Global Systemic Psoriasis Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Mild Psoriasis Case Studies
Figure 6. Moderate Psoriasis Case Studies
Figure 7. Severe Psoriasis Case Studies
Figure 8. Systemic Psoriasis Therapeutics Report Years Considered
Figure 9. Global Systemic Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Systemic Psoriasis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Systemic Psoriasis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Systemic Psoriasis Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Systemic Psoriasis Therapeutics Market Share by Players in 2020
Figure 14. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Psoriasis Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2020
Figure 16. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Systemic Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Systemic Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Systemic Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Systemic Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Systemic Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Systemic Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Systemic Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Systemic Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Systemic Psoriasis Therapeutics Market Share by Region (2016-2027)
Figure 38. China Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Systemic Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Systemic Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Systemic Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Systemic Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Systemic Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Systemic Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Systemic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2016-2021)
Figure 59. Celgene Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
世界の慢性尋常性乾癬治療市場規模・現状・予測（2021年-2027年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…- 世界の尋常性乾癬治療市場規模・現状・予測（2021年-2027年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…
- 世界の全身感染療法市場規模・現状・予測（2021年-2027年） Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the person’s bloodstream and gradually spreads to the whole body. The systemic infections can range from common ones such as flu, …
- 世界の全身感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Infection Treatment Market The global Systemic Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の全身性特発性若年性関節炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…